Amy (Grekowicz) Parker, Mph
About Amy (Grekowicz) Parker, Mph
Amy Parker is the Vice President of Clinical Operations with a strong background in epidemiology and clinical studies, having previously contributed to significant drug approvals.
Amy Parker's Educational Background
Amy Parker holds a Master of Public Health in Epidemiology from San Diego State University. She also earned a Bachelor of Arts in Political Science and Psychology from the University of California, San Diego (UCSD). Her educational background has provided her with a comprehensive understanding of public health, epidemiology, social sciences, and human behavior.
Professional Role as Vice President of Clinical Operations
Amy Parker currently holds the title of Vice President of Clinical Operations. In this role, she is responsible for the planning and execution of clinical studies, clinical budgeting, process improvement, vendor partnerships, and oversight. Her expertise is vital in ensuring that clinical operations run smoothly and efficiently, meeting all regulatory and company standards.
Experience at Oncternal Therapeutics
Prior to her current role, Amy Parker worked at Oncternal Therapeutics as Vice President of Clinical Operations. During her tenure, she made significant contributions, including being a part of the successful New Drug Application (NDA) for Sutent. Additionally, she served as the clinical operations lead for the Talzenna NDA team, showcasing her leadership and expertise in the field.
Early Career in Research at UCSD and Stanford Medical Center
Before transitioning to the pharmaceutical industry, Amy Parker worked as a study coordinator at the University of California, San Diego and Stanford Medical Center. These roles provided her with valuable experience in research coordination, laying a solid foundation for her subsequent positions in clinical operations and management.